Document is current
Any future updates will be listed below
-
Authors
Fritz, Bailey R.
Kleinhenz, Michael D.
Magnin, Geraldine
Griffin, Jason J.
Weeder, Mikaela M.
Curtis, Andrew K.
Martin, Miriam S.
Nelson, Alyssa A.
Kleinhenz, Katie E.
Johnson, Blaine T.
Fritz, Scott A.
Montgomery, Shawnee R.
Tkachenko, Andriy
Coetzee, Johann F.
-
Funding
Funding for this research was provided by:
National Institute of Food and Agriculture (2020-67030-31479, 2020-67030-31479, 2020-67030-31479, 2020-67030-31479)
U.S. Food and Drug Administration (Vet-LIRN 1U18FD006915-01, Vet-LIRN 1U18FD006915-01)
- License Information
-
More Information
Article History
Received: 21 July 2025
Accepted: 28 October 2025
First Online: 27 November 2025
Declarations
:
: The authors declare no competing interests.
: The authors have no conflicts of interest to disclose.
: Raw cannabinoid concentration data, sorted by tissue, can be viewed in Supplementary Tables S1-8, additional dose calculation details in Supplementary Table S9, UPLC-MS quality control data and multiple reaction monitoring parameters in Supplementary Tables S10-13, and FDA WithdrawalApp reports can be viewed in the Supplementary Reports R1-R24.
